adsilico Raises £10M Series A

adsilico, a University of Leeds spinout based in the United Kingdom, has secured £10M in Series A funding to expand its AI-driven virtual patient modeling platform. The startup focuses on addressing clinical trial diversity gaps by generating synthetic hearts and blood vessels for medical device testing. Including this latest round, the company has raised a total of £13.5M.

Investors

The funding round was led by PXN Ventures. Participating investors include Northern Gritstone and Parkwalk.

adsilico Use of Funds

The company plans to use the capital to extend its heart model portfolio to cover neurovascular devices, particularly flow diverters for brain aneurysms. Additionally, the funding will support the growth of their team from 14 to 34 employees at the University of Leeds' Nexus innovation hub.

About adsilico

Founded in 2024 by Sheena Macpherson, Dr. Nishant Ravikumar, and Dr. Zeike Taylor, adsilico uses generative AI and clinical scans to create virtual hearts and blood vessels for medical device manufacturers. Their platform enables simulated testing on diverse patient populations to improve device design and reduce clinical trial biases.

Funding Details

Company Website: https://adsilico.uk

Company: adsilico
Raised: £10M
Round: Series A
Funding Date: October 26, 2026
Lead Investor: PXN Ventures
Additional Investors: Northern Gritstone, Parkwalk
Software Category: Medtech
Source: https://techfundingnews.com/adsilico-10m-series-a-ai-virtual-patients-medtech/